ArticlePublic health challenges2022
Towards a post-COVID world: Challenges and progress of recovery in Kazakhstan.
Article in Public health challenges, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Public Health Communication Challenges in Eastern Europe and Central Asia: A Scoping Review.International journal of environmental research and public health · 2025Article
- A mixed method exploration of job morale of physicians working in public healthcare settings in Kazakhstan during the COVID-19 pandemic.Journal of health, population, and nutrition · 2025Article
- Outpatient pediatric care during the COVID-19 pandemic, Almaty, Kazakhstan 2021-2022.Frontiers in public health · 2025Article
- Interrupted time series analysis of the impact of the COVID-19 pandemic and compulsory social health insurance system on fertility rates: a study of live births in Kazakhstan, 2019-2023.Frontiers in public health · 2024Article
- Article
- The COVID-19 pandemic and mental health in Kazakhstan.Global mental health (Cambridge, England) · 2023Article
- Towards a post-COVID world: Challenges and progress of recovery in Kazakhstan.Public health challenges · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kazakhstan announced the first cases of COVID-19 in March 2020. Within a span of a few months, the pandemic ravaged all regions affecting vulnerable populations due to limited access to healthcare services and co-morbidities. To minimize the spread of the pandemic, the government announced the implementation of containment measures such as quarantine, movement restrictions, and lockdowns among others. The collateral effect of the pandemic has disrupted economic and learning activities pushing several people below the poverty line. The pandemic revealed the weakness of healthcare including the acute shortage of essential medicines and lack of hospital beds. This calls for stringent measures to revive the economy and mitigate the reeling effect of the pandemic. As a result, Kazakhstan commenced COVID-19 vaccination efforts in February 2021. To date, about 47.8% are fully vaccinated pushing Kazakhstan closer to achieving herd immunity at the 60% threshold. However, the country faces challenges such as vaccine hesitancy and uncertainty surrounding vaccine effectiveness against new variants of SARS-CoV2, among others. This paper aims to explore the health and socioeconomic challenges caused by COVID-19 in Kazakhstan, control strategies, vaccination campaigns and progress towards herd immunity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.